Association of Nadir Prostate-specific Antigen >0.5 ng/mL after Dose-escalated External Beam Radiation with Prostate Cancer-specific Endpoints

Objective Prior studies have suggested that prostate-specific antigen (PSA) nadir of 0.5 ng/mL is an important surrogate endpoint for prostate cancer-specific and all-cause mortality. This study analyzed our well-followed patient cohort to assess whether this endpoint was associated with differences...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheth, Niki, Youssef, Irini, Osborn, Virginia, Lee, Anna, Safdieh, Joseph, Schreiber, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089484/
https://www.ncbi.nlm.nih.gov/pubmed/30112266
http://dx.doi.org/10.7759/cureus.2790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089484/
https://www.ncbi.nlm.nih.gov/pubmed/30112266
http://dx.doi.org/10.7759/cureus.2790

Ejemplares similares